Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Gains from Sales and Divestitures: 2010-2020

Historic Gains from Sales and Divestitures for National Research (NRC) over the last 7 years, with FY2020 value amounting to $71378.0.

  • National Research's Gains from Sales and Divestitures changed N/A to $71378.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $71378.0, marking a year-over-year change of. This contributed to the annual value of $71378.0 for FY2020, which is N/A changed from last year.
  • As of FY2020, National Research's Gains from Sales and Divestitures stood at $71378.0.
  • National Research's 5-year Gains from Sales and Divestitures high stood at $73506.0 for FY2017, and its period low was $13611.0 during FY2018.
  • Moreover, its 4-year median value for Gains from Sales and Divestitures was $46135.0 (2016), whereas its average is $44846.8.
  • In the last 5 years, National Research's Gains from Sales and Divestitures soared by 25183.8% in 2017 and then tumbled by 8148.31% in 2018.
  • Annual analysis of 4 years shows National Research's Gains from Sales and Divestitures stood at $20892.0 in 2016, then surged by 251.84% to $73506.0 in 2017, then plummeted by 81.48% to $13611.0 in 2018, then skyrocketed by 424.41% to $71378.0 in 2020.
  • Its last three reported values are $71378.0 in FY2020, $13611.0 for FY2018, and $73506.0 during FY2017.